Mingjia Capital
Overview
Mingjia Capital is an early-stage venture capital firm based in Beijing, China that invests in the entertainment, online media, video, virtual reality, and consumer goods sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HaploX | Jul 2021 | Series C | Co-investor |
| Shanghai Desano Pharmaceutical Group Co., Ltd. | Feb 2023 | Private Equity | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Mingjia Capital based?
Mingjia Capital is headquartered in Beijing, China.
When was Mingjia Capital founded?
Mingjia Capital was founded in 2015.
How many portfolio companies does Mingjia Capital have?
Mingjia Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Mingjia Capital's portfolio?
Portfolio companies visible on Caplight include HaploX, Shanghai Desano Pharmaceutical Group Co., Ltd..
What was Mingjia Capital's most recent investment shown here?
Mingjia Capital's most recent investment in this portfolio sample was in Shanghai Desano Pharmaceutical Group Co., Ltd. in 2023.
What sectors does Mingjia Capital focus on?
Mingjia Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Mingjia Capital focus on?
Stage focus information for Mingjia Capital is not publicly available.